Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 3Completed 1

Sponsor Class

UNKNOWN 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Head and Neck Neoplasms 41Squamous Cell Carcinoma of Head and Neck 37Prostatic Neoplasms 16Nasopharyngeal Carcinoma 12Carcinoma, Non-Small-Cell Lung 12Glioblastoma 11Uterine Cervical Neoplasms 10Gliosarcoma 10Brain Neoplasms 10Neoplasm Metastasis 9Carcinoma, Squamous Cell 8Breast Neoplasms 8Rectal Neoplasms 7Pancreatic Neoplasms 7Glioma 7Carcinoma 7Tongue Neoplasms 6Radiation Injuries 6Oropharyngeal Neoplasms 6Neoplasms 6Lung Neoplasms 6Astrocytoma 6Sarcoma 5Nasopharyngeal Neoplasms 5Papillomavirus Infections 4Endometrial Neoplasms 4Salivary Gland Neoplasms 3Oligodendroglioma 3Mouth Neoplasms 3Laryngeal Neoplasms 3

Interventions

fludarabine phosphate 19Peripheral Blood Stem Cell Transplantation 17Whole-Body Irradiation 15Mycophenolic Acid 14Cyclophosphamide 14Cyclosporine 12Busulfan 12Methotrexate 9Etoposide 9Tacrolimus 8Bortezomib 7Antilymphocyte Serum 7Everolimus 5Dexamethasone 5Vorinostat 4Rituximab 4Panobinostat 4Gemcitabine 4Flow Cytometry 4Carboplatin 4thymoglobulin 3Transplantation 3Therapeutics 3Radiotherapy 3Pharmacogenomic Testing 3Methylprednisolone 3Melphalan 3In Situ Hybridization, Fluorescence 3Gene Expression Profiling 3Early Intervention, Educational 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Lymphoma, Extranodal NK-T-Cell × Radiotherapy, Intensity-Modulated × Clear all
NCT02276248 2017-08-16

Radiotherapy Combined With GDP Chemotherapy in Stage I/II Extranodal Natural Killer/T-cell Lymphoma

ChineseAMS

Phase 2 Completed
40 enrolled
Lymphoid

Lymphoma, Extranodal NK-T-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡